Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osamu Yasuda

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 22, 2019
Anemia is an independent risk factor for cardiovascular and renal events in hypertensive outpatients with well-controlled blood pressure: a subgroup analysis of the ATTEMPT-CVD randomized trialShokei Kim-Mitsuyama, Hirofumi Soejima, Osamu Yasuda, et al.
Journal of Cardiology Cases|December 15, 2018
A case of Werner's syndrome with cardiac syndrome X and heart failure with preserved ejection fractionMasahiro Yamamoto, Eiichiro Yamamoto, Osamu Yasuda, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 1, 2007
Tissue inhibitor of metalloproteinase-3 deficiency inhibits blood pressure elevation and myocardial microvascular remodeling induced by chronic administration of Nomega-nitro-L-arginine methyl ester in miceMasayoshi Higuchi, Osamu Yasuda, Hidenobu Kawamoto, et al.
Biochemical and Biophysical Research Communications|June 18, 2011
Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activityKensuke Toyama, Taishi Nakamura, Keiichiro Kataoka, et al.
Endocrine|April 16, 2009
Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activationYoshihiro Maekawa, Kazuhiko Ishikawa, Osamu Yasuda, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 2004
Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathwaysToshimitsu Suhara, Keisuke Fukuo, Osamu Yasuda, et al.
Biochemical and Biophysical Research Communications|November 4, 2008
Akt activation prevents Apop-1-induced death of cellsXin Sun, Osamu Yasuda, Yukihiro Takemura, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 24, 2010
Ezetimibe ameliorates cardiovascular complications and hepatic steatosis in obese and type 2 diabetic db/db miceMasaya Fukuda, Taishi Nakamura, Keiichiro Kataoka, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 17, 2006
Tissue inhibitor of metalloproteinase-3 plays important roles in the kidney following unilateral ureteral obstructionHidenobu Kawamoto, Osamu Yasuda, Takashi Suzuki, et al.
FEBS Letters|January 24, 2007
Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cellsTakamori Yotsui, Osamu Yasuda, Hidenobu Kawamoto, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 22, 2019
Anemia is an independent risk factor for cardiovascular and renal events in hypertensive outpatients with well-controlled blood pressure: a subgroup analysis of the ATTEMPT-CVD randomized trialShokei Kim-Mitsuyama, Hirofumi Soejima, Osamu Yasuda, et al.
Journal of Cardiology Cases|December 15, 2018
A case of Werner's syndrome with cardiac syndrome X and heart failure with preserved ejection fractionMasahiro Yamamoto, Eiichiro Yamamoto, Osamu Yasuda, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 1, 2007
Tissue inhibitor of metalloproteinase-3 deficiency inhibits blood pressure elevation and myocardial microvascular remodeling induced by chronic administration of Nomega-nitro-L-arginine methyl ester in miceMasayoshi Higuchi, Osamu Yasuda, Hidenobu Kawamoto, et al.
Biochemical and Biophysical Research Communications|June 18, 2011
Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activityKensuke Toyama, Taishi Nakamura, Keiichiro Kataoka, et al.
Endocrine|April 16, 2009
Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activationYoshihiro Maekawa, Kazuhiko Ishikawa, Osamu Yasuda, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 2004
Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathwaysToshimitsu Suhara, Keisuke Fukuo, Osamu Yasuda, et al.
Biochemical and Biophysical Research Communications|November 4, 2008
Akt activation prevents Apop-1-induced death of cellsXin Sun, Osamu Yasuda, Yukihiro Takemura, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 24, 2010
Ezetimibe ameliorates cardiovascular complications and hepatic steatosis in obese and type 2 diabetic db/db miceMasaya Fukuda, Taishi Nakamura, Keiichiro Kataoka, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 17, 2006
Tissue inhibitor of metalloproteinase-3 plays important roles in the kidney following unilateral ureteral obstructionHidenobu Kawamoto, Osamu Yasuda, Takashi Suzuki, et al.
FEBS Letters|January 24, 2007
Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cellsTakamori Yotsui, Osamu Yasuda, Hidenobu Kawamoto, et al.
Pageof 6